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Epithelial-mesenchymal transition (EMT) is a developmental process in which epithelial cells acquire the mo-
tile, migratory properties ofmesenchymal cells. In a recent issue ofCell, Mani et al. (2008) show that induction
of EMT stimulates cultured breast cells to adopt characteristics of stem cells.Epithelial-mesenchymal transition (EMT)
is a physiological phenotypic shift in
which epithelial cells break down cell-
cell and cell-extracellular matrix connec-
tions and then migrate to other locations
in the body. Once the migrating mesen-
chymal cells have reached their destina-
tion, they can undergo a reverse EMT, a
mesenchymal-epithelial transition (MET).
During embryonic development, EMT cre-
ates cells that act as progenitors of many
different tissues. For example, gastrula-
tion EMT produces the mesoderm, giving
rise to a wide range of cell types, including
muscle, bone, and connective tissues,
whereas neural crest delamination EMT
gives rise to glial and neuronal cells, adre-
nal glandular tissues, pigment-containing
cells of the epidermis, and skeletal and
connective tissues (Figures 1A and 1B)
(Shook and Keller, 2003). EMT functions
in adults to facilitate organ morphogene-
sis as well as tissue regeneration and
regrowth during wound repair. However,
there is an increasing awareness that
EMT-associated processes can contrib-
ute to invasive and metastatic tumor
growth (Figure 1C); consequently, consid-
erable effort is being expended to identify
the mechanisms involved in EMT induc-
tion and maintenance (Hugo et al., 2007;
Thiery and Sleeman, 2006). EMT can be
induced in mammary epithelial cells by
exposure to certain cytokines, such as
TGF-b1, or by exogenous expression of
various transcription factors, including
those of the Twist or Snail families (Thiery
and Sleeman, 2006; Zavadil and Bot-
tinger, 2005). Significantly, activation of
these processes in breast cancer cells
greatly increases their invasive and meta-
static potential, but some argument still
exists as to exactly how EMT participatesin progression of tumors to metastasis
(Hugo et al., 2007).
How an induced EMT might impact the
various epithelial cells in the mammary
gland is unknown. A developmental hier-
archy has been demonstrated in this tis-
sue in which stem cells give rise to both
the outer myoepithelial layer and the inner
layer of luminal epithelial cells, which de-
fine the bilayered architecture of the
branching mammary gland (Shackleton
et al., 2006; Stingl et al., 2006; Villadsen
et al., 2007). Normal human mammary
tissue contains a subpopulation of
EpCamhigh/CD49fhigh stem cells that give
rise to mammospheres and to bilayered,
branching structures in 3D culture (Villad-
sen et al., 2007). A direct etiological link
between normal stem cells and cancer
has been postulated due to the observa-
tion that cells within tumors exhibit attri-
butes of stem cells, but the exact relation-
ship remains elusive. Al Hajj Al-Hajj et al.
(2003) isolated a CD44high/CD24low sub-
population of breast cancer pleural
effusions and showed that these cells
generated tumors in a xenograft model
more effectively than did the majority
population of CD44low/CD24high cells.
The CD44high/CD24low cells were subse-
quently designated as ‘‘cancer stem
cells’’ (CSCs), and this discovery has fu-
eled investigation of CSCs as the meta-
static component of cancer (Hermann
et al., 2007). In the present work, Mani
et al. (2008) demonstrate that cells from
normal human and mouse mammary tis-
sues with functional properties of stem
cells are also CD44high/CD24low and, en-
ticingly, that the surface phenotype can
be induced by EMT (Figure 1D). Thus,
the authors have identified a potential
link between EMT, which endows cellsCell Stemwith migratory and invasive capabilities,
and cells with properties of CSC.
Mani et al. (2008) found that cultured
normal human mammary epithelial cells
contained both CD44high/CD24low and
CD44low/CD24high subpopulations and
that isolated CD44high/CD24low cells
displayed a mesenchymal morphology
and expressed characteristic mesen-
chymal markers. This population also
demonstrated many of the properties of
stem cells, including enhanced mammo-
sphere-forming ability and differentiation
into cells expressing lineage-specific
markers of myoepithelial or luminal epi-
thelial cells. The isolated CD44high/
CD24low cells, when grown on tissue cul-
ture plastic, regenerated both CD44high/
CD24low and CD44low/CD24high cell popu-
lations, whereas culture of CD44low/
CD24high cells did not give rise to
CD44high/CD24low cells. Analysis of the
stem cell population from mouse mam-
mary glands (CD49fhigh/CD24medium)
showed that cells that could regenerate
mammary glandular structures when in-
jected into cleared fat pads also displayed
a mesenchymal morphology and ex-
pressed mesenchymal markers. These
experiments suggest either that stemcells
normally have characteristics associated
with mesenchymal cells or that a subpop-
ulation of normal mammary epithelial cells
possesses both stem cell-like properties
and the mesenchymal phenotype.
In a pivotal series of experiments, Mani
and colleagues found that normal mam-
mary epithelial cells could be induced to
adopt the CD44high/CD24low expression
profile when exposed to TGF-b1 for 12
days or when EMT-inducing transcription
factors Snail or Twist were conditionally
overexpressed for the same time period.Cell 2, June 2008 ª2008 Elsevier Inc. 511
Cell Stem Cell
PreviewsThe resulting population dis-
played mesenchymal morphol-
ogy and surface markers, and it
grew much more effectively in
mammosphere culture. These
experiments suggested that
EMT was sufficient to induce
a population with characteristics
of stem cells, and they pointed
to the exciting possibility that
the processes by which develop-
mental EMT generates numer-
ous cell types from the meso-
derm or neural crest may be
related to the processes by
which breast progenitor cells
give rise to cells of the mammary
gland. One important unresolved
question is how treatment with
TGF-b1 or expression of Snail
or Twist leads to the evolution
of the CD44high/CD24low popula-
tion. One possibility is that exist-
ing CD44low/CD24high cells were
converted to CD44high/CD24low
cells by the EMT-inducing stimu-
lus; this hypothesis suggests the
remarkable possibility that the
majority CD44low/CD24high sub-
population has the potential to
adopt stem cell-like characteris-
tics. An alternative possibility is
that the EMT stimuli inhibited
proliferation of the CD44low/
CD24high subpopulation and
also either induced proliferation
or inhibited differentiation of the
CD44high/CD24low cells. This
model implies a potential role for
EMT-associated processes in
normal stem cell function, either
their expansion or maintenance.
Defining the response of isolated
CD44low/CD24high cells to the EMT stimuli
could potentially resolve this issue.
An exciting implication of these results
is that there may be a direct relationship
between EMT and the phenomenon of
CSCs. As discussed above, breast
CSCs were defined as a CD44high/
CD24low subpopulation of cancer cells
that is enriched for tumorigenic cells
(Al-Hajj et al., 2003); Mani et al. (2008)
now show that EMT inducers confer
upon breast cancer cells both increased
malignancy and the CD44high/CD24low
expression pattern. Because a number
of studies have shown that inducers of
EMT can cause cancer cells to become
more tumorigenic (Hugo et al., 2007), it
may be that CSCs are not distinct entities
but rather tumor cells that transiently
acquire stem cell-like properties as a con-
sequence of a regulatable EMT.
This model may provide insight
into current questions about the
specific role of EMT in tumor pro-
gression (Hugo et al., 2007).
Most tumors do not harbor a
significant proportion of cells
with traditional characteristics of
EMT, such as increased expres-
sion of the intermediate filament
protein vimentin or the acquisi-
tion of mesenchymal morphology
(Hugo et al., 2007); identification
of CD44high/CD24low as specifi-
cally relevant characteristics of
EMT-facilitated tumormalignancy
could help to resolve this long-
standing and critical issue.
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Figure 1. EMT Is a Developmental Process that Can Be
Hijacked during Pathogenesis
(A) Gastrulation. Formation of the mesoderm by EMT produces the
third embryonic layer.
(B) Neural crest delamination. EMT of neuroepithelial cells is the key
step for induction of the neural crest.
(C) Cancer progression. EMT facilitates intravasation of tumor cells
into blood or lymph vessels and subsequent formation of distant me-
tastases.
(D) In the new report by Mani et al. (2008) in Cell, experimentally in-
duced EMT in mammary epithelial cells is shown to generate cells
with a CD44high/CD24low phenotype: a phenotype that gained notori-
ety as a putative marker of breast cancer stem cells.512 Cell Stem Cell 2, June 2008 ª2008 Elsevier Inc.
